Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$324,892,907
+$49,293,929 QoQ
Shares Held
1,291,102
+1.9% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#114
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Korea Investment CORP holds $2,440,943,887 across 10 Drug Manufacturers - General names. ABBV ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
658,950 | $790,364,464 | |
| 2 | JNJ |
Johnson & Johnson
|
1,849,714 | $469,771,864 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,291,102 | $324,892,907 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,861,405 | $239,190,542 | |
| 5 | AZN |
Astrazeneca PLC
|
1,242,006 | $235,509,177 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,003,135 | $126,736,075 | |
| 7 | AMGN |
Amgen Inc
|
269,926 | $97,745,603 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,501,534 | $86,518,389 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,892,907 | 1,291,102 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $275,598,978 | 1,267,180 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $346,448,190 | 1,516,251 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $358,921,731 | 1,550,150 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $252,733,324 | 1,361,563 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $281,037,556 | 1,341,340 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $235,423,712 | 1,324,838 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $268,443,055 | 1,359,343 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $213,037,273 | 1,242,055 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $259,998,009 | 1,427,776 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $236,359,004 | 1,525,192 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $216,183,059 | 1,450,309 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $181,780,949 | 1,349,224 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $231,283,640 | 1,451,237 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $240,702,257 | 1,489,402 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $207,716,817 | 1,547,700 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $235,324,826 | 1,536,464 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $226,869,054 | 1,399,476 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $155,665,182 | 1,149,669 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $115,727,898 | 1,072,846 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $114,361,815 | 1,015,286 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $107,235,847 | 990,906 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $118,198,236 | 1,103,110 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $109,900,749 | 1,254,718 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $128,578,295 | 1,309,618 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $69,811,373 | 916,280 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||